This inventor holds 2 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignees: Glaxosmithkline Biologicals Sa, Novartis Ag. Active years: 2015-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Castelnuovo Berardenga, IT (2015)
- Siena, IT (2018)
Company Filing History:
Years Active: 2015-2018
Title: The Innovative Contributions of Erika Bartolini
Introduction
Erika Bartolini is a prominent inventor based in Siena, Italy. She has made significant contributions to the field of biotechnology, particularly in the development of vaccines utilizing outer membrane vesicles (OMV). With a total of 2 patents, her work is paving the way for advancements in medical treatments and diagnostics.
Latest Patents
Bartolini's latest patents focus on OMV vaccines. These inventions are centered around the use of outer membrane vesicles obtained from a bacterium that is an ompA mutant and/or a mutant in one or more components of the TolPal complex. The OMV presents a heterologous antigen on its surface, which is selected from a group consisting of CT823, CT681, CT372, CT443, CT043, CT733, CT279, CT601, and CT153. This innovative approach aims to enhance the treatment, prevention, or diagnosis of infections.
Career Highlights
Throughout her career, Erika Bartolini has worked with leading companies in the pharmaceutical industry, including Novartis AG and GlaxoSmithKline Biologicals SA. Her experience in these organizations has contributed to her expertise in vaccine development and biotechnology.
Collaborations
Bartolini has collaborated with notable colleagues such as Renata Grifantini and Oretta Finco. These partnerships have further enriched her research and innovation in the field.
Conclusion
Erika Bartolini's contributions to the field of biotechnology, particularly through her patents on OMV vaccines, highlight her role as a leading inventor. Her work continues to influence advancements in medical science and public health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile